GlaxoSmithKline Company Profile
We have a challenging and inspiring mission: to improve the quality of human life by enabling people to do more, feel better and live longer. This mission gives us the purpose to develop innovative medicines and products that help millions of people around the world. In fact, we are the only pharmaceutical company to tackle the World Health Organization’s three ‘priority’ diseases – HIV/AIDS, tuberculosis and malaria.
Headquartered in the UK and with operations based in the US, we are one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market.
Location
980 Great West Road
Brentford
Middlesex
TW8 9GS
United States of America
Contact
Phone: +1 888 825 5249 or +1 888 825 5249
News Articles
GlaxoSmithKline will Mehrheit an indischer Tochter
Von Ashutosh Joshi MUMBAI--Der britische Pharmakonzern GlaxoSmithKline will seine Beteiligung an der indischen Tochter GlaxoSmithKline Consumer Healthcare Ltd kräftig aufstocken. Der Konzern hält .....
$500,000 endowment gift from the GlaxoSmithKline Foundation
The Children's Hospital of Philadelphia is proud to announce a $500,000 gift from the GlaxoSmithKline (GSK) Foundation. The donation will greatly enhance the GlaxoSmithKline Hope for Families Fund, an...
Auxilium, GlaxoSmithKline to co-promote Testim in US
Auxilium Pharmaceuticals and GlaxoSmithKline LLC, the US subsidiary of GlaxoSmithKline plc, have entered into an agreement for the co-promotion of Testim 1% (testosterone gel).
GlaxoSmithKline - A Few Reasons Not To Buy In Now
By ValueMax:Current shareholders should continue to hold GlaxoSmithKline (GSK) until at least the next earnings release; interested investors may consider other pharmas as more viable ROI opportunitie...
GlaxoSmithKline-Aktie: Pharmaunternehmen kämpft weiterhin mit branchenspezifischen Herausforderungen
Hamburg - Marco Günther, Analyst der Hamburger Sparkasse, stuft die GlaxoSmithKline-Aktie (ISIN GB0009252882/ WKN 940561) von "verkaufen" auf "halten" herauf.Nach wie vor habe GlaxoSmithKline mit d.....
GlaxoSmithKline-Aktie: Projekt-Pipeline mit begrenztem Potenzial
Genf - Odile Rundquist, Analystin von Helvea, stuft die GlaxoSmithKline-Aktie (ISIN GB0009252882/ WKN 940561) weiterhin mit "neutral" ein.GlaxoSmithKline habe einen Conference Call zum Bereich Fors...
GlaxoSmithKline to pay $3B for health fraud(2)
British drugmaker GlaxoSmithKline will pay $3 billion in fines — the largest heathcare fraud settlement in U.S. history — for criminal and civil violations involving 10 drugs that are taken by mi...
MALVERN, Pa. and PHILADELPHIA, May 21, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) and GlaxoSmithKline LLC, the U.S. subsidiary of GlaxoSmithKline plc (LSE: GSK), announced toda...
Drugs and Medications
Phazyme [GlaxoSmithKline Consumer Healthcare LP]
Drug Facts
Panadol [GlaxoSmithKline Consumer Healthcare LP]
Drug Facts
Gaviscon [GlaxoSmithKline Consumer Healthcare LP]
Drug Facts
Phazyme [Preferred Pharmaceuticals, Inc]
Drug Facts
Gaviscon [GlaxoSmithKline Consumer Healthcare LP]
Drug Facts
PubMed Articles
Two rotavirus vaccines are currently approved in the United States: 3-dose RotaTeq (RV5; Merck & Co., Inc., Whitehouse Station, NJ, USA) is administered at ages 2, 4, and 6 months; and 2-dose Rotarix...
GlaxoSmithKline opens the door on clinical data sharing.
Alkaloid synthesis: Indolizidines with ease.
Aims: IL-13 is implicated as an important mediator of the pathology of asthma. This first clinical study with GSK679586, a novel humanized anti-IL-13 IgG1 monoclonal antibody, evaluated the safety, ph...
Clinical Trials
Infection with human papillomavirus (HPV) has been clearly established as the central cause of cervical cancer. The current study is designed to assess the immunogenicity and safety of Gla...
Infection with human papillomavirus (HPV) has been clearly established as the central cause of cervical cancer. The current study is designed to evaluate the safety and immunogenicity of G...
The present study is designed to assess the lot-to-lot consistency of the immunogenicity of a GlaxoSmithKline Biologicals' pandemic influenza candidate vaccine (GSK1562902A) in adults age...
Safety & Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A
The purpose of this observer-blind study is to evaluate the safety and immunogenicity of GlaxoSmithKline Biologicals' investigational Herpes Zoster vaccine GSK1437173A when administered as...
Swine Flu (Novel Influenza A H1N1) Vaccine Study
In the first half of this year a novel Influenza A H1N1 virus has resulted in an influenza pandemic. The United Kingdom has seen a particularly high incidence of disease. The highest rates...
Companies
GlaxoSmithKline Consumer Healthcare
GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation pro...
GlaxoSmithKline â one of the worldâs leading research-based pharmaceutical and healthcare companies â is committed to improving the quality of human life by enablin...
One of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and liv...
More Information about "GlaxoSmithKline" on BioPortfolio
We have published hundreds of GlaxoSmithKline news stories on BioPortfolio along with dozens of GlaxoSmithKline Clinical Trials and PubMed Articles about GlaxoSmithKline for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GlaxoSmithKline Companies in our database. You can also find out about relevant GlaxoSmithKline Drugs and Medications on this site too.
